The Department of Justice vows to protect access to abortions amid restrictive legislation; wide distribution of Pfizer’s COVID-19 booster shot is expected to begin the week of September 20; adult residents from states that lifted eviction moratoriums exhibit increased risk of COVID-19 infection.
With the Supreme Court allowing Texas to enact its law on banning abortions after approximately 6 weeks of pregnancy, the Department of Justice (DOJ) announced today it would protect people’s access to the procedure. As reported by USA Today, the law has no exemptions in cases of rape or incest and would also allow citizens to sue providers and anyone involved in “aiding and abetting” abortions. Notably, abortion providers said the law would restrict 85% of procedures in Texas.
Reported by CNBC, White House Chief Medical Advisor Anthony Fauci, MD, said yesterday that wide distribution of Pfizer’s booster shot against COVID-19 is expected to begin the week of September 20. Pending approval from public health officials, the Pfizer booster dose may get FDA and CDC approval in time for the expected date, whereas Moderna’s third dose may be delayed further. Fauci recommended for people who were given 2 doses of the Moderna vaccine to wait for its third dose instead of taking a Pfizer booster. US data on mixing vaccines from different manufacturers is expected to be published in the next few weeks, added Fauci.
According to research published in JAMA Network Open, adult residents from US states that lifted eviction moratoriums implemented during the pandemic were found to be at increased risk for COVID-19 in the 5 to 12 weeks that followed compared with states where the bans remained. Reported by CIDRAP, this research comes as the Supreme Court recently said the CDC exceeded its authority in implementing a national eviction moratorium on September 4, 2020, when approximately 47% of residents from rental properties were likely to have faced eviction. Highest risks of infection were observed in residents with underlying medical conditions, those living in lower socioeconomic areas, and people paying high rents.
Unmet Needs Remain in Secondary AML Following Treatment With HMAs
January 18th 2025The study demonstrated a poor prognosis overall for patients with acute myeloid leukemia (AML) who were previously treated with hypomethylating agents (HMAs) for myeloid neoplasms such as myelodysplastic syndromes.
Read More
Increased Interest in Advance Provision and Over-the-Counter Medication Abortion
January 16th 2025An increased public interest and support for medication abortion following the federal Supreme Court ruling, particularly among marginalized groups, suggests a shift towards more accessible and autonomous models of abortion care.
Read More
Frameworks for Advancing Health Equity: Pharmacy Support for Non-Hodgkin Lymphoma
December 19th 2024Rachael Drake, pharmacy technician coordinator, University of Kansas Health System, explains how her team collaborates with insurance companies and providers to support treatment access for patients with non-Hodgkin lymphoma.
Listen
Study Suggests Postdischarge Care Needs Targeted, Multifaceted Approaches
January 15th 2025The findings challenge the effectiveness of these widely used transitional care interventions and suggest a need for more targeted, multifaceted approaches to address the needs of higher-risk patients.
Read More